Podcast

Diabetes Dialogue: Mental Health and PRO Standardization, with Katharine Barnard-Kelly, PhD

In this episode, hosts sit down with Katharine Barnard-Kelly, PhD, at ATTD 2023 to discuss the evolving recognition of the role of psychology in diabetes management for both pediatric and adult populations.

The annual conference on Advanced Technologies and Treatments for Diabetes (ATTD) is no stranger to ground-breaking work and initiatives. Considered by many the foremost international meeting on diabetes technologies, the meeting also serves as an opportunity for collaboration among leaders on other aspects of diabetes management, including the role of psychology and mental health.

This type of collaboration is what Katharine Barnard-Kelly, PhD, professor of Health Psychology with Southern Health NHS Foundation Trust, sought out at this year’s conference. At present, Barnard-Kelly is leading an effort to develop a consensus statement on the standardization of person-reported outcomes (PROs) to improve the mental and physical health of people with diabetes in both pediatric and adult populations. The consensus statement, which has yet to have been finalized, was the subject of a symposium at ATTD 2023 in Berlin, Germany, which was led by Barnard-Kelly and Frank Snoek, PhD, director of the diabetes psychology research and care team at Amsterdam University Medical Center.

Recognizing the increasing emphasis on psychology and mental health in diabetes management as well as an interest in learning more about her work and the statement itself, the hosts of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives Diana Isaacs, PharmD, an endocrine clinical pharmacist and CGM program coordinator at the Cleveland Clinic, and Natalie Bellini, DNP, an endocrine nurse practitioner with R&B Medical Group, sat down with Barnard-Kelly during their time at ATTD 2023.

Related Videos
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
4 experts are featured in this series.
4 experts are featured in this series.
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.